These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2276184)

  • 1. [The effect of the emergent vaccination using DTP vaccine to control the outbreak of pertussis].
    Sun D
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Dec; 11(6):345-7. PubMed ID: 2276184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of children with diagnosed pertussis].
    Kardas-Sobantka D; Golebiowska M; Libich M; Stryjewska I
    Przegl Epidemiol; 2000; 54(3-4):357-65. PubMed ID: 11349599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results with a new DTP vaccine in Japan.
    Kimura M; Hikino N
    Dev Biol Stand; 1985; 61():545-61. PubMed ID: 2872131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis notifications in Australia, 1991 to 1997.
    Andrews R; Herceg A; Roberts C
    Commun Dis Intell; 1997 May; 21(11):145-8. PubMed ID: 9188218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines.
    Chan GJ; Moulton LH; Becker S; Muñoz A; Black RE
    Int J Epidemiol; 2007 Oct; 36(5):1022-9. PubMed ID: 17646186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of acellular pertussis vaccine in young infants.
    Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
    J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
    Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of pertussis in a closed population with a high vaccination rate.
    Shvartzman P; Swartz T; Stopler T; Herman J
    Isr J Med Sci; 1991 Mar; 27(3):137-40. PubMed ID: 2016153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Kheirkhah T; Ghazanfari M; Shokri F
    Iran J Immunol; 2007 Jun; 4(2):101-9. PubMed ID: 17652850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain].
    González López A; Arístegui Fernández J; Díez-Delgado J; Dal-Ré Saavedra R
    An Esp Pediatr; 1998 Feb; 48(2):132-7. PubMed ID: 9577019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.